Rigel Pharmaceuticals, Inc. (RIGL)
31.95
-0.18
(-0.56%)
USD |
NASDAQ |
May 14, 12:03
Rigel Pharmaceuticals Market Cap : 591.14M for May 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 182.17B |
| Madrigal Pharmaceuticals, Inc. | 12.46B |
| Xencor, Inc. | 885.99M |
| CytomX Therapeutics, Inc. | 816.39M |
| AnaptysBio, Inc. | 1.823B |
Market Cap Related Metrics
| PE Ratio | 1.707 |
| PS Ratio | 2.046 |
| PEG Ratio | 0.0021 |
| Price to Book Value | 1.478 |
| Price to Free Cash Flow | 7.738 |
| Price | 31.95 |
| Earnings Yield | 58.59% |
| PEGY Ratio | 0.0021 |
| Operating PE Ratio | 4.924 |
| Normalized PE Ratio | 1.707 |